Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PAWEL T POMIANOWSKI

Allopathic & Osteopathic Physicians Medical Genetics Clinical Genetics (M.D.)

NPI
1659586352
CMS profile
780643
Location
JACKSON, MS

General Payments · PY2021–2024

$941.74

  • Reported across 18 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$921.50

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $921.50 17

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $20.24 1
PY2024 $921.50 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2021 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alnylam Pharmaceuticals Inc. $17.89 08/21/2024 Food and Beverage Undisputed 01/23/2026 1125839493 CMS
Alnylam Pharmaceuticals Inc. $90.71 12/17/2024 Food and Beverage Undisputed 01/23/2026 1125839511 CMS
AstraZeneca Pharmaceuticals LP $87.61 04/18/2024 Food and Beverage Undisputed 01/23/2026 1105507726 CMS
AstraZeneca Pharmaceuticals LP $23.73 07/23/2024 Food and Beverage Undisputed 01/23/2026 1104270625 CMS
AstraZeneca Pharmaceuticals LP $1.42 07/23/2024 Food and Beverage Undisputed 01/23/2026 1104505164 CMS
AstraZeneca Pharmaceuticals LP $34.68 08/13/2024 Food and Beverage Undisputed 01/23/2026 1105493437 CMS
AstraZeneca Pharmaceuticals LP $19.68 11/13/2024 Food and Beverage Undisputed 01/23/2026 1105803155 CMS
GENZYME CORPORATION $24.40 02/06/2024 Food and Beverage Undisputed 01/23/2026 1139864592 CMS
GENZYME CORPORATION $60.11 04/08/2024 Food and Beverage Undisputed 01/23/2026 1139864606 CMS
GENZYME CORPORATION $16.97 05/14/2024 Food and Beverage Undisputed 01/23/2026 1139864612 CMS
GENZYME CORPORATION $51.13 06/20/2024 Food and Beverage Undisputed 01/23/2026 1139864648 CMS
GENZYME CORPORATION $32.98 08/27/2024 Food and Beverage Undisputed 01/23/2026 1139864646 CMS
HEARTFLOW, INC. $120.77 07/18/2024 Food and Beverage Undisputed 01/23/2026 1154181066 CMS
Myriad Genetic Laboratories, Inc. $74.43 05/08/2024 Food and Beverage Undisputed 01/23/2026 1152538235 CMS
Myriad Genetic Laboratories, Inc. $24.85 11/14/2024 Food and Beverage Undisputed 01/23/2026 1152538237 CMS
Novo Nordisk Inc $126.72 08/15/2024 Food and Beverage Undisputed 01/23/2026 1097613052 CMS
Philips North America LLC $113.42 03/21/2024 Food and Beverage Undisputed 01/23/2026 1146884668 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.